News

Tilray Brands Announces Implementation of Previously Approved 1-for-10 Reverse Stock Split

Common Stock Expected to Begin Trading on a Split-Adjusted Basis on December 2, 2025NEW YORK, Nov. 26, 2025 (GLOBE NEWSWIRE)…

4 weeks ago

Orchestra BioMed Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

NEW HOPE, Pa., Nov. 26, 2025 (GLOBE NEWSWIRE) -- Orchestra BioMed Holdings, Inc. (Nasdaq: OBIO) (“Orchestra BioMed” or the “Company”),…

4 weeks ago

Mineralys Therapeutics Reports Inducement Award Under Nasdaq Listing Rule 5635(c)(4)

RADNOR, Pa., Nov. 26, 2025 (GLOBE NEWSWIRE) -- Mineralys Therapeutics, Inc. (Nasdaq: MLYS), a clinical-stage biopharmaceutical company focused on developing…

4 weeks ago

Celcuity to Present Updated Data from the PIK3CA Wild-Type Cohort of the Phase 3 VIKTORIA-1 Trial at the 2025 San Antonio Breast Cancer Symposium

MINNEAPOLIS, Nov. 26, 2025 (GLOBE NEWSWIRE) -- Celcuity Inc. (Nasdaq: CELC), a clinical-stage biotechnology company pursuing development of targeted therapies…

4 weeks ago

Psyched Wellness Launches Calmer, a 2x Version of Calm and an Enhanced Flavour Profile for Calm

Toronto, Ontario--(Newsfile Corp. - November 27, 2025) - Psyched Wellness Ltd. (CSE: PSYC) (OTCQB: PSYCF) (FSE: 5U9) (the "Company" or…

4 weeks ago

Neuraxpharm and mjn-neuro announce plans to launch EPISERAS®, a digital health solution using an AI-powered wearable device for the early detection of epileptic seizures

A non-invasive, AI-based, wearable earpiece that continuously monitors brain activity to enable the early detection of seizure risk in real…

4 weeks ago

Protagenic Therapeutics Announces Receipt of Nasdaq Non-Compliance Notice

NEW YORK, NY / ACCESS Newswire / November 27, 2025 / Protagenic Therapeutics, Inc. (Nasdaq:PTIX) (the "Company") today announced that…

4 weeks ago

GLG Life Tech Corporation Reports 2025 Third Quarter Financial Results

VANCOUVER, BC / ACCESS Newswire / November 26, 2025 / GLG Life Tech Corporation (NEX:GLG.H) ("GLG" or the "Company"), a…

1 month ago

Zealthy Under Review: The 2025 Doctor-Led GLP-1 Weight Loss Program That’s Changing the Industry

NEW YORK CITY, NY / ACCESS Newswire / November 26, 2025 / Is the future of weight loss found in…

1 month ago

HeartBeam Provides Update on Regulatory Path Following FDA Decision on 12-Lead ECG Synthesis Software Application

Company engaging in multiple options for a constructive resolution Strategy is underpinned by a clinical study that achieved the agreed…

1 month ago